Skip Navigation

European Heart Journal 2000 21(1):39-44; doi:10.1053/euhj.1999.1695
Copyright © 2000 by the European Society of Cardiology.
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (8)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Leyva, F
Right arrow Articles by Stevenson, J.C
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Leyva, F
Right arrow Articles by Stevenson, J.C
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Non-invasive assessment of vascular function. Paradoxical vascular response to intravenous glucose in coronary heart disease

F Leyvaa,b,f1, M Rauchhausa, S.D Ankera, A.J Proudlerb, I.F Godslandb, P Stiefelc, A.J.S Coatsa, P.A Poole-Wilsona and J.C Stevensonb

a Department of Cardiac Medicine, Imperial College School of Medicine at the National Heart and Lung Institute, London, U.K.
b Rosen Laboratories of the Wynn Institute, Endocrinology and Metabolism, Imperial College School of Medicine, St Mary's Campus, London, U.K.
c Hypertension and Lipids Unit, Hospital Vírgen del Rocio, Sevilla, Spain

revised May 4, 1999; accepted May 5, 1999

Abstract

Background In healthy individuals, insulin administration causes an increase in forearm blood flow which is dependent on the effects of insulin on the vascular endothelium. Glucose, administered as an intravenous bolus, produces a transient hyperinsulinaemic response. We hypothesized that the insulin response to an intravenous glucose challenge during the intravenous glucose tolerance test might lead to increases in forearm blood flow in healthy individuals, and that such a response might be altered in patients with coronary heart disease.

Methods and Results Healthy individuals (n=10, aged 41·6±3·0 years, mean±SEM) and patients with angiographically proven coronary heart disease (n=13, aged 65·5±2·4 years) underwent an intravenous glucose tolerance test with simultaneous measurement of right forearm blood flow at 28 time points, using mercury-in-silastic venous occlusion plethysmography. In controls, forearm blood flow increased to a mean of 31·7% above baseline values at 7min and remained above baseline up to 180min after intravenous glucose. In contrast, patients with coronary heart disease exhibited an opposite response, with forearm blood flow decreasing to a mean of –16·2% below baseline values at 7min and –25·8% at 180min. Marked group differences emerged in net changes from baseline in forearm blood flow throughout the intravenous glucose tolerance test, expressed as incremental areas under the forearm blood flow profiles (controls: +351·3±121·7; coronary heart disease patients: –244·3±72·4minml–1.100ml–1,P =0·001).

Conclusions We have demonstrated for the first time that in healthy individuals forearm blood flow increases after an intravenous bolus of glucose, and that paradoxically, this response is reduced below baseline forearm blood flow in patients with coronary heart disease. Further studies are needed to determine whether plethysmographic measurement of forearm blood flow after an intravenous bolus of glucose could provide a clinically useful non-invasive test for the diagnosis of occult coronary heart disease.

Key Words: Endothelium, insulin, atherosclerosis

f1 Correspondence: Dr Francisco Leyva, Department of Cardiology, Royal Brompton Hospital, Sydney Street, London SW3 6NP, U.K. e-mail:leyvaleon@hotmail.com


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
M. G. Clark, M. G. Wallis, E. J. Barrett, M. A. Vincent, S. M. Richards, L. H. Clerk, and S. Rattigan
Blood flow and muscle metabolism: a focus on insulin action
Am J Physiol Endocrinol Metab, February 1, 2003; 284(2): E241 - E258.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
C. Basso, F. Calabrese, D. Corrado, and G. Thiene
Postmortem diagnosis in sudden cardiac death victims: macroscopic, microscopic and molecular findings
Cardiovasc Res, May 1, 2001; 50(2): 290 - 300.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
W. Doehner, I. F. Godsland, and S. D. Anker
Vascular effect of insulin in endothelial dysfunction
J. Am. Coll. Cardiol., February 1, 2001; 37(2): 689 - 689.
[Full Text] [PDF]


Home page
Eur Heart JHome page
W. Bagg, G.D. Braatvedt, and N. Sharpe
A complex relationship: glucose, insulin and coronary artery disease
Eur. Heart J., January 1, 2000; 21(1): 8 - 9.
[PDF]



Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.